insights_auto
Why is ARX up 2.50%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
A$0.49
arrow_upward
+2.50%(+0.012) 1D
Nov 17, 4:00:00 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.49
High
A$0.50
Low
A$0.48
Mkt. cap
170.18M
Avg. vol.
265.00K
Volume
313.07K
P/E ratio
46.95
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.49
High
A$0.50
Low
A$0.48
Mkt. cap
170.18M
Avg. vol.
265.00K
Volume
313.07K
P/E ratio
46.95
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
ChartMill
·
35 minutes ago
S&P 500 Stocks Gapping Down in Today's Session
TradingView
·
1 hour ago
Wells Fargo sets 2027 S&P 500 year-end target at 8,200
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd